The objective of this single-center retrospective observational study is to describecognitive and psychological outcomes and their impact on quality of life after at least 3months of intensive care unit (ICU) discharge in severe COVID-19 survivors.
Background: The COVID-19 pandemic has already affected more than 600 million people
worldwide and resulted in at least 6 million deaths (https:coronavirus.jhu.edu/map.html).
The pandemic has also resulted in a growing population of individuals recovering from
acute SARS-CoV-2 infection. Accumulating observational data suggest that these patients
often experience a wide range of symptoms after recovery from acute illness. The
dysfunctions ranging from motor, cognitive disability, anxiety, depression and
post-traumatic stress disorder. However, there is still unknown data about the occurrence
of mental health manifestations after a critical illness and their consequences in mid
term quality of life.
Purpose: Many patients with coronavirus disease 2019 (COVID-19) required critical care.
Mid-term outcomes of the survivors need to be assessed. The objective of this
single-center retrospective observational study is to describe their cognitive and
psychological outcomes and their impact on quality of life afer at least 3 months
following intensive care unit (ICU)-discharge.
Objectives: Our objective will be to evaluate the incidence of non-physical
post-intensive care syndrome, such as symptoms of anxiety, depression, cognitive and
post-traumatic stress disorder (PTSD) after hospital discharge in our severe COVID-19
population, as well as determining their long-term consequences in quality of life (QoL).
Methods: An observational retrospective study will be conducted, including all patients
with severe COVID-19 admitted to the intensive care unit of a private tertiary hospital
from April 2020 to October 2021. Patients were routinely assessed after 3 months of ICU
discharge in our multidisciplinary follow-up clinic. A trained research team routinely
applied the Montreal Cognitive Assessment Scale (MOCA), Hospital Anxiety and Depression
Scale (HADS), PCL-C (Post-traumatic Stress Disorder Checklist: Civilian Version) and
Short Form Health Survey 36 (SF-36), during the follow-up evaluation.
Diagnostic Test: Montreal cognitive assessment scale (MOCA)
Tests to evaluate cognitive disorders (MOCA), anxiety and depression (HADS) Pos-traumatic
stress disorder (PCL-C) and quality of life (SF-36)
Other Name: Hospital anxiety and depression scale ( HADS),Post-traumatic stress disorder checklist civilian version (PCL-C),Short form health survey 36 (SF-36)
Inclusion Criteria:
- All 18 years and older patients with severe COVID-19, confirmed by real-time reverse
transcriptase-polymerase chain reaction., admitted to a 15- bed intensive care unit
of a tertiary hospital from April 2020 to October 2021.
Exclusion Criteria:
- Still hospitalized or inpatient in rehabilitation facility
- Previous cognitive impairmant
Not Provided
JOSE R AZEVEDO, MD, PhD
+559832168110
jrazevedo47@gmail.com
JOAQUIM C LOBATO FILHO, MD
+559832168110
joaquimhclobato@gamil.com